Waldron Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Buy
26,341
+599
+2% +$140K 0.23% 50
2026
Q1
$6.29M Sell
25,742
-102
-0.4% -$23.8K 0.25% 49
2025
Q4
$5.35M Buy
25,844
+144
+0.6% +$28.5K 0.21% 52
2025
Q3
$4.77M Sell
25,700
-1,820
-7% -$312K 0.19% 60
2025
Q2
$4.2M Sell
27,520
-1,376
-5% -$212K 0.18% 60
2025
Q1
$4.79M Sell
28,896
-10,904
-27% -$1.71M 0.23% 54
2024
Q4
$5.76M Sell
39,800
-760
-2% -$118K 0.23% 57
2024
Q3
$6.57M Buy
40,560
+1,761
+5% +$281K 0.27% 51
2024
Q2
$5.67M Sell
38,799
-2,905
-7% -$432K 0.25% 55
2024
Q1
$6.6M Buy
41,704
+1,762
+4% +$280K 0.3% 48
2023
Q4
$6.26M Sell
39,942
-2,308
-5% -$354K 0.3% 49
2023
Q3
$6.58M Sell
42,250
-2,212
-5% -$365K 0.34% 43
2023
Q2
$7.36M Buy
44,462
+1,432
+3% +$231K 0.37% 41
2023
Q1
$6.67M Buy
43,030
+135
+0.3% +$21.8K 0.32% 41
2022
Q4
$7.01M Hold
42,895
0.44% 42
2022
Q3
$7.01M Buy
42,895
+1,638
+4% +$277K 0.44% 42
2022
Q2
$7.32M Buy
41,257
+133
+0.3% +$23.7K 0.41% 45
2022
Q1
$7.29M Buy
41,124
+2,499
+6% +$425K 0.37% 46
2021
Q4
$6.61M Buy
38,625
+189
+0.5% +$30.9K 0.33% 52
2021
Q3
$6.21M Buy
38,436
+5,666
+17% +$967K 0.36% 47
2021
Q2
$5.4M Buy
32,770
+22
+0.1% +$3.64K 0.35% 46
2021
Q1
$5.38M Sell
32,748
-201
-0.6% -$32.5K 0.37% 44
2020
Q4
$5.18M Sell
32,949
-154
-0.5% -$22.7K 0.39% 44
2020
Q3
$4.93M Buy
33,103
+235
+0.7% +$34.8K 0.42% 39
2020
Q2
$4.62M Buy
32,868
+19
+0.1% +$2.77K 0.41% 40
2020
Q1
$4.31M Sell
32,849
-90
-0.3% -$12.8K 0.46% 41
2019
Q4
$4.8M Buy
32,939
+1,470
+5% +$199K 0.43% 39
2019
Q3
$4.07M Buy
31,469
+6,604
+27% +$870K 0.41% 41
2019
Q2
$3.46M Buy
24,865
+937
+4% +$130K 0.37% 35
2019
Q1
$3.34M Buy
23,928
+4,021
+20% +$539K 0.38% 38
2018
Q4
$2.57M Buy
19,907
+3,202
+19% +$447K 0.37% 38
2018
Q3
$2.31M Buy
16,705
+2,358
+16% +$313K 0.45% 27
2018
Q2
$1.74M Sell
14,347
-1,910
-12% -$238K 0.38% 30
2018
Q1
$2.08M Buy
16,257
+90
+0.6% +$12.2K 0.47% 28
2017
Q4
$2.26M Buy
16,167
+3,243
+25% +$452K 0.53% 24
2017
Q3
$1.68M Buy
12,924
+2,430
+23% +$322K 0.47% 25
2017
Q2
$1.39M Sell
10,494
-6,166
-37% -$787K 0.44% 22
2017
Q1
$2.06M Buy
16,660
+5,969
+56% +$713K 0.52% 24
2016
Q4
$1.23M Buy
10,691
+1,122
+12% +$130K 0.42% 29
2016
Q3
$1.13M Sell
9,569
-631
-6% -$76.6K 0.41% 27
2016
Q2
$1.24M Buy
10,200
+327
+3% +$37.2K 0.45% 26
2016
Q1
$1.07M Sell
9,873
-2,364
-19% -$245K 0.4% 29
2015
Q4
$1.26M Buy
12,237
+2,251
+23% +$226K 0.47% 21
2015
Q3
$932K Buy
9,986
+1,458
+17% +$141K 0.4% 24
2015
Q2
$831K Buy
8,528
+1,546
+22% +$155K 0.33% 27
2015
Q1
$702K Buy
6,982
+319
+5% +$32.4K 0.29% 27
2014
Q4
$697K Buy
6,663
+58
+0.9% +$6.11K 0.29% 30
2014
Q3
$704K Sell
6,605
-840
-11% -$87.1K 0.33% 30
2014
Q2
$779K Buy
7,445
+1,295
+21% +$131K 0.36% 28
2014
Q1
$604K Sell
6,150
-4
-0.1% -$371 0.29% 31
2013
Q4
$564K Buy
+6,154
New +$567K 0.26% 35

Other funds holding JNJ

Waldron Private Wealth's JNJ Position: Q2 2026 in Review

Waldron Private Wealth increased its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, buying an estimated $140K and bringing the position to 26,341 shares worth $6.69M. The position accounts for 0.23% of the portfolio, ranked #50.

Waldron Private Wealth first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. The position peaked at $7.36M in Q2 2023. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Waldron Private Wealth held 26,341 shares of Johnson & Johnson worth $6.69M as of Q2 2026.
  • Waldron Private Wealth bought 599 Johnson & Johnson shares in Q2 2026, an estimated $140K.
  • Johnson & Johnson made up 0.23% of Waldron Private Wealth's portfolio in Q2 2026, its #50 holding.
  • Waldron Private Wealth first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
  • Waldron Private Wealth's Johnson & Johnson position peaked at $7.36M in Q2 2023.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.